Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice

Life Sciences

Volumn 59, Issue 21, 1996, Pages

  Takai, Shinji ^a   Song, Keifu ^a   Tanaka, Toyoo ^a   Okunishi, Hideki ^b   Miyazaki, Mizuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

blood brain barrier; brain angiotensin II; endogenous opioids; naloxone

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRAIN ENZYME; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IODINE 125; LOSARTAN; NALOXONE; OPIATE RECEPTOR; SPIRAPRIL; TRANDOLAPRIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AUTONOMIC NERVOUS SYSTEM; AUTORADIOGRAPHY; BINDING SITE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG ANTAGONISM; ENZYME BLOOD LEVEL; HOT PLATE TEST; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 0030592526     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00527-9     Document Type: Article

References (13)

1. 1. D. GANTEN, R.E. LANG, E. LEHMANN and T. UNGER, Biochem. Pharmacol. 33 3523-3528 (1984).
2. 2. F.A.O. MENDELSOHN, R. QUIRION, J.M. SAAVEDRA, G. AGUILERA and K.J. CATT, Proc. Natl. Acad. Sci. U.S.A. 81 1575-1579 (1984).
3. 3. S. KANEKO, A. MORI, S. TAMURA, M. SATOH and H. TAKAGI, Neuropharmacology 24 1131-1134 (1985).
4. 4. H. OKUNISHI, T. KAWAMOTO, Y. KUROBE, Y. OKA, K. ISHII, T. TANAKA and M. MIYAZAKI, Clin. Exper. Pharmacol. Physiol. 18 649-359 (1991).
5. 5. H. OKUNISHI, T. KAWAMOTO, T. KOBAYASHI, H. SAKONJO and M. MIYAZAKI, Pharm. Pharmacol. Lett. 2 180-183 (1992).
6. 6. K. SONG, J. ZHUO and F.A.O. MENDELSOHN, Br. J. Pharmacol. 104 771 -772 (1991).
7. 7. W.B. EDDY and D. LEIMBACH, J. Pharmacol. Exp. Ther. 107 385-393 (1953).
8. 8. M. MIYAZAKI, H. OKUNISHI, K. NISHIMURA and N. TODA, Clin. Sci. 66 39-45 (1984).
9. 9. P. GOHLKE, H. URBACH, B. SCHOLKENS and T. UNGER, J. Pharmacol. Exp. Ther. 249 609-619 (1989).
10. 10. S.M. STINE, H.Y. YANG and E. COSTA, Brain Research 188 295-299 (1980).
11. 11. J.A. NORMAN, W.L. AUTRY and B.S. BARBAZ, Mol. Pharmacol. 28 521-526 (1985).
12. 12. E.G. ERDOS, A.R. JOHNSON and N.T. Boyden, Biochem. Pharmacol. 27 843-848 (1978).
13. 13. J.Y. SUMMY-LONG, L.C. KEIL, K. DEEN, L. ROSELLA and W.B. SEVERS, J. Pharmacol. Exp. Ther. 217 619-629 (1981).